1	Dysregulation	dysregulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	monocytic	monocytic	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factor-kappa	factor-kappa	_	_	_	_	_	_	_
6	B	b	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	oxidized	oxidize	_	_	_	_	_	_	_
9	low-density	low-density	_	_	_	_	_	_	_
10	lipoprotein	lipoprotein	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Nuclear	nuclear	_	_	_	_	_	_	_
2	factor-kappa	factor-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B)/Rel	B)/Rel	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	factors	factor	_	_	_	_	_	_	_
9	may	may	_	_	_	_	_	_	_
10	be	be	_	_	_	_	_	_	_
11	involved	involve	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	atherosclerosis	atherosclerosis	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	as	as	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	suggested	suggest	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	presence	presence	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	activated	activate	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	human	human	_	_	_	_	_	_	_
27	atherosclerotic	atherosclerotic	_	_	_	_	_	_	_
28	lesions	lesion	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	aim	aim	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	present	present	_	_	_	_	_	_	_
6	study	study	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	investigate	investigate	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	effects	effect	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	oxidized	oxidize	_	_	_	_	_	_	_
14	LDL	LDL	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	oxLDL	oxldl	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	on	on	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	system	system	_	_	_	_	_	_	_
23	in	in	_	_	_	_	_	_	_
24	human	human	_	_	_	_	_	_	_
25	THP-1	thp-1	_	_	_	_	_	_	_
26	monocytic	monocytic	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	as	as	_	_	_	_	_	_	_
29	well	well	_	_	_	_	_	_	_
30	as	as	_	_	_	_	_	_	_
31	adherent	adherent	_	_	_	_	_	_	_
32	monocytes	monocyte	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	demonstrate	demonstrate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	short-term	short-term	_	_	_	_	_	_	_
6	incubation	incubation	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	oxLDL	oxldl	_	_	_	_	_	_	_
12	activated	activate	_	_	_	_	_	_	_
13	p50/p65	p50/p65	_	_	_	_	_	_	_
14	containing	contain	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	dimers	dimer	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	induced	induce	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	target	target	_	_	_	_	_	_	_
25	gene	gene	_	_	_	_	_	_	_
26	IL-8	il-8	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	antioxidant	antioxidant	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	H2O2	h2o2	_	_	_	_	_	_	_
13	scavenger	scavenger	_	_	_	_	_	_	_
14	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
15	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	proteasome	proteasome	_	_	_	_	_	_	_
19	inhibitor	inhibitor	_	_	_	_	_	_	_
20	PSI	PSI	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	oxLDL-induced	oxldl-induced	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	accompanied	accompany	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	initial	initial	_	_	_	_	_	_	_
11	depletion	depletion	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	I	i	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B-alpha	B-alpha	_	_	_	_	_	_	_
16	followed	follow	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	a	a	_	_	_	_	_	_	_
19	slight	slight	_	_	_	_	_	_	_
20	transient	transient	_	_	_	_	_	_	_
21	increase	increase	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	level	level	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	this	this	_	_	_	_	_	_	_
27	inhibitor	inhibitor	_	_	_	_	_	_	_
28	protein	protein	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	long-term	long-term	_	_	_	_	_	_	_
5	treatment	treatment	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	oxLDL	oxldl	_	_	_	_	_	_	_
8	prevented	prevent	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	lipopolysaccharide-induced	lipopolysaccharide-induced	_	_	_	_	_	_	_
11	depletion	depletion	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	I	i	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B-alpha	B-alpha	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	accompanied	accompany	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	an	an	_	_	_	_	_	_	_
20	inhibition	inhibition	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	both	both	_	_	_	_	_	_	_
23	NF-kappa	NF-kappa	_	_	_	_	_	_	_
24	B	B	_	_	_	_	_	_	_
25	activation	activation	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	expression	expression	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	tumor	tumor	_	_	_	_	_	_	_
31	necrosis	necrosis	_	_	_	_	_	_	_
32	factor-alpha	factor-alpha	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	interleukin-1	interleukin-1	_	_	_	_	_	_	_
35	beta	beta	_	_	_	_	_	_	_
36	genes	gene	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	provide	provide	_	_	_	_	_	_	_
4	additional	additional	_	_	_	_	_	_	_
5	evidence	evidence	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	oxLDL	oxldl	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	potent	potent	_	_	_	_	_	_	_
11	modulator	modulator	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	suggest	suggest	_	_	_	_	_	_	_
17	that	that	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	dys)regulation	dys)regulation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B/Rel	B/Rel	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	likely	likely	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	play	play	_	_	_	_	_	_	_
27	an	an	_	_	_	_	_	_	_
28	important	important	_	_	_	_	_	_	_
29	role	role	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	atherogenesis	atherogenesis	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

